908-359-8980 Menu

Improving the health of our patients through groundbreaking clinical research

The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.

Current Clinical Trials:

Study: Acne

Purpose: To evaluate the safety and efficacy of the investigational Cutera® 1726 nm laser system (also referred to as ‘Alice’) for the treatment of mild to severe acne vulgaris. Subjects will receive three 1726 nm laser treatments at 3 week intervals. Follow-up visits will occur at approximately 10 days post each treatment (via phone) and at 4-, 12-, 26- and 52-weeks post-final treatment.


  • Female and male subjects, ages 16 to 60 years
  • Fitzpatrick skin types I-IV with mild, moderate, or severe acne vulgaris

Duration: Approx. 18 months

Location: Hackensack, NJ

Compensation: $325

To participate contact Diana Aranzazu, [email protected], 201-951-0701

Study: Vitiligo Trial

Purpose: Vitiligo is a skin condition in which there is a loss of color (referred to as “depigmentation”) from areas of skin. This results in uneven white patches that have no pigment, but the skin feels like normal. The purpose of the study you are being asked to participate in is to evaluate the safety and effectiveness of the RECELL® Device when used for repigmentation of stable vitiligo. Stable vitiligo means that the areas affected by loss of pigment have been unchanged for at least the last 12 months. The study will evaluate the effect of using RECELL for repigmentation.


  • Male and Females, 18 years or older
  • Diagnosed with Focal, segmental or generalized (i.e., nonsegmental) vitiligo photographically documented as stable (No new lesions within the previous 12 months)

Duration: Approx. 52 weeks

Location: Hackensack, NJ

Compensation: If all visits kept, up to $1350 will be paid to patient *once all visits are completed*

To participate contact Diana Aranzazu, [email protected], 201-951-0701

Study: Alopecia Areata

Purpose: This research study will look at two different doses of CTP-543 compared to placebo (looks like the study drug, but does not contain active ingredients) when given to research subjects with alopecia areata (sudden hair loss) twice-daily for 24 weeks. The main purpose is to determine if CTP-543 will result in hair regrowth, and to see if taking CTP-543 is safe.


  • Male and Females, ages 18 to 65 inclusive
  • Definitive diagnosis of alopecia areata with a current episode of scalp hair loss lasting at least 6 months and not exceeding 10 years at the time of Screening. Total disease duration greater than 10 years is permitted.
  • At least 50% scalp hair loss, as defined by a SALT score ≥50, at Screening and Baseline.

Duration: Approx. 28 weeks

Location: Hackensack, NJ

Compensation: If all visits kept, up to $500 will be paid to patient *once all visits are completed*

To participate contact Diana Aranzazu, [email protected], 201-951-0701

Study: Atopic dermatitis

Purpose: A clinical research study to test the effectiveness of an investigational medication to reduce symptoms.


  • Male and Females, ages 12 and older
  • Have moderate to severe atopic dermatitis for at least 2 years
  • Failure to improve with topical prescriptions

Duration: 60 weeks/visiting doctor’s office at least 16 times

Location: Hackensack, NJ

Compensation: If all visits are kept, up to $1000 will be paid to the patient *once all visits are completed*

To participate contact Diana Aranzazu, [email protected], 201-951-0701

Study: Buttock Toning

Purpose: Simultaneous Application of High-Intensity Focused Electromagnetic Procedure and Radiofrequency for Toning of Buttocks. Subjects of both groups will be required to complete four (4) treatment visits and two follow-up visits. All of the study subjects will receive the treatment with the subject device.


  • Adults 21 years of age or older
  • Desire to treat skin laxity in the butt region.
  • BMI ≤ 35 kg/m2

Duration: Approx. 12 weeks

Compensation: TBD

Study: Naso-Labial Folds Volume Restoration

Purpose: To Evaluate the Effects of RENUVA® HD Treatment on Human Skin Quality and Nasolabial Fold Volume Restoration. Subject with moderate deep wrinkles to very deep wrinkles of the nasolabial folds will receive 1 treatment using Renuva on the right and left side of the face and the right infra auricular area (behind/below their ear). Subject will undergo 5 biopsy procedures of the right treated infra auricular area: pre-treatment, day 30, day 60, day 90, and day 180 after treatment to evaluate if Renuva induces Collagen and Elastin production.


  • Healthy female or male volunteers with moderate deep wrinkles to very deep wrinkles of the nasolabial folds

Duration: Approx. 6 months

Compensation: $375

Study: Treatment to Lift Loose Hanging Skin

Purpose: To evaluate the safety and efficacy of Sofwave treatment to lift lax tissue in the submental and neck zones and to lift the eyebrow. This study is a two-arm study. Eligible patients will receive 2-4 face and/or neck and/or submental or “off the face” (abdomen, or arms, or thighs, or Décolleté) treatments (per PI discretion, 2-12 weeks apart) using the Sofwave System. Follow up visits will be conducted at 3 and 6 months post final treatment.


  • Healthy female and male subjects between the ages 35-80.
  • Non-Smoker.
  • Fitzpatrick skin type I-VI.
  • Desire to lift loose hanging skin in the neck and submental and/or to lift the brows.

Duration: Approx. 6-8 months

Compensation: $240 for study visits/ $1200 for biopsies taken

Interested in participating in our clinical research study?

Contact: Diana Aranzazu
[email protected]

What to expect during a clinical trial:

  • Access to new investigational treatments before they are made widely available
  • Financial compensation for participation
  • An opportunity to contribute to the advancement of medical science through research
  • Study visits conducted by a trained and dedicated research team
  • Adherence to strict industry and safety standards.
  • Evaluations performed by one of our certified provide

To learn more contact: Diana Aranzazu, [email protected], 201-951-0701

Schedule A Consultation

Contact Us

We are proud to announce that Skin Laser & Surgery Specials of NY & NJ has joined Schweiger Dermatology.

Learn More about our revised in-office safety policies in response to the COVID-19 outbreak.

Practice Policy Update Regarding COVID-19

The health and safety of our patients and staff is our top priority. Our in-office safety policies are aligned with the latest guidelines issued by the CDC and local government officials related to COVID-19.

New safety policies for patients:

  • Patients will undergo screening questions and receive comprehensive instructions about our new policies prior to their appointment.
  • To minimize contact, we will offer patients virtual check in and check out.
  • Patients will be instructed to come to the office wearing a mask.
  • Patient temperatures will be checked via forehead scanners upon arrival to the office.
  • We have reorganized our offices to maximize social distancing and cleanliness, and we have altered workflows to allow patients to wait outside or in their cars until their exam room is ready. Patients will be contacted via text message or phone call when the provider is ready for the visit to begin.
  • We are asking for patients to arrive at their appointment alone. For children and adult patients who require a caretaker, one adult may accompany the patient.
  • Patients who are sick or have had exposures to COVID-19 will be rescheduled.
  • Offices will be cleaned and disinfected frequently throughout the day.
  • Teledermatology appointments remain available for patients who prefer to be seen virtually.

New safety policies for office & staff:

  • All of our staff have completed training on all new workflows and infection prevention measures.
  • All of our clinical staff will be wearing appropriate personal protective equipment (PPE) during patient encounters to include masks and eye protection.
  • Our exam rooms are sanitized before and after every patient visit.
  • All SLSS team members will be screened for symptoms and/or fever daily prior to coming to work.
Contact Us